Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Prevention of Alopecia in Patients With Localised Breast Cancer 08/25/2023 INTERVENTIONAL not-comparable 1,142.75 0 Character-Strengths Based Coaching For Work-Stress Reduction For Health Workers 08/28/2023 INTERVENTIONAL not-comparable 1,139.75 0 Post-market Prospective Clinical Study of Nagor Perle Mammary Implants 08/28/2023 OBSERVATIONAL not-comparable 1,139.75 0 IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer 08/28/2023 INTERVENTIONAL not-comparable 1,139.75 0 Efficacy and Adverse Side Effects of Two Forms of Iron in Pregnancy 08/28/2023 INTERVENTIONAL not-comparable 1,139.75 0 The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes 08/30/2023 INTERVENTIONAL not-comparable 1,137.75 0 Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer 08/30/2023 INTERVENTIONAL not-comparable 1,137.75 0 Analysis of Varus Collapse in Obese Patients With Stem and Non-Stem Tibial Components Following Primary Total Knee Arthroplasty 08/31/2023 INTERVENTIONAL not-comparable 1,136.75 0 Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer 08/31/2023 OBSERVATIONAL not-comparable 1,136.75 0 Hydroxychloroquine May be Beneficial for Preeclampsia 08/31/2023 OBSERVATIONAL not-comparable 1,136.75 0 Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity 08/31/2023 OBSERVATIONAL not-comparable 1,136.75 0 Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7 09/01/2023 INTERVENTIONAL not-comparable 1,135.75 0 Pessary Experience Study 09/01/2023 OBSERVATIONAL not-comparable 1,135.75 0 Characterization of the Pudendal Nerve With Transvaginal Ultrasonography 09/01/2023 OBSERVATIONAL not-comparable 1,135.75 0 Prenatal Sonographic Prediction of Placental Histology and Function 09/01/2023 OBSERVATIONAL not-comparable 1,135.75 0 Sex Hormones, Postoperative Pain and Opioid Use 09/05/2023 OBSERVATIONAL not-comparable 1,131.75 0 A Study of Blood Pressure Control During Cancer Treatment 09/05/2023 INTERVENTIONAL not-comparable 1,131.75 0 Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF 09/05/2023 INTERVENTIONAL not-comparable 1,131.75 0 A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) 09/05/2023 INTERVENTIONAL not-comparable 1,131.75 0 Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy 09/06/2023 OBSERVATIONAL not-comparable 1,130.75 0 Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial 09/06/2023 INTERVENTIONAL not-comparable 1,130.75 0 Young Patients With Early Breast Cancer 09/07/2023 OBSERVATIONAL not-comparable 1,129.75 0 Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer 09/07/2023 INTERVENTIONAL not-comparable 1,129.75 0 Melodi Matrix™ in Breast Reconstruction 09/07/2023 INTERVENTIONAL not-comparable 1,129.75 0 PRP Injections for Genitourinary Syndrome of Menopause 09/07/2023 INTERVENTIONAL not-comparable 1,129.75 0 Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors 09/07/2023 INTERVENTIONAL not-comparable 1,129.75 0 International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study 09/08/2023 OBSERVATIONAL not-comparable 1,128.75 0 Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6 09/08/2023 INTERVENTIONAL not-comparable 1,128.75 0 A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients 09/08/2023 INTERVENTIONAL not-comparable 1,128.75 0 Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I) 09/08/2023 OBSERVATIONAL not-comparable 1,128.75 0 The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry 09/08/2023 OBSERVATIONAL not-comparable 1,128.75 0 Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women 09/11/2023 INTERVENTIONAL not-comparable 1,125.75 0 Artificial Intelligence in Mammography Screening in Norway 09/13/2023 INTERVENTIONAL not-comparable 1,123.75 0 Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus 09/13/2023 INTERVENTIONAL not-comparable 1,123.75 0 PRO for Fighting FT in Ovarian Cancer 09/13/2023 OBSERVATIONAL not-comparable 1,123.75 0 PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia 09/13/2023 INTERVENTIONAL not-comparable 1,123.75 0 Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer 09/13/2023 OBSERVATIONAL not-comparable 1,123.75 0 Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer 09/13/2023 INTERVENTIONAL not-comparable 1,123.75 0 LATe Cerclage in High-risk Pregnancies (LATCH) 09/14/2023 INTERVENTIONAL not-comparable 1,122.75 0 ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial 09/14/2023 INTERVENTIONAL not-comparable 1,122.75 0 Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma 09/15/2023 OBSERVATIONAL not-comparable 1,121.75 0 Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer 09/18/2023 INTERVENTIONAL not-comparable 1,118.75 0 A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years 09/18/2023 INTERVENTIONAL not-comparable 1,118.75 0 Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism 09/18/2023 INTERVENTIONAL not-comparable 1,118.75 0 Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair 09/18/2023 INTERVENTIONAL not-comparable 1,118.75 0 AM vs PM Exercise Training 09/18/2023 INTERVENTIONAL not-comparable 1,118.75 0 Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs 09/18/2023 INTERVENTIONAL not-comparable 1,118.75 0 UmbrelLACT Study: Clinical Lactation Study on the Exposure to Medicines Via Human Milk 09/21/2023 OBSERVATIONAL not-comparable 1,115.75 0 A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer 09/21/2023 INTERVENTIONAL not-comparable 1,115.75 0 Discovering New Insights Into Anorexia Nervosa: Influence of MicrObial DysbiosiS (DIAMOnDS) 09/21/2023 INTERVENTIONAL not-comparable 1,115.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology